• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更多专业,更少问题:利用传染病学、足病学和病理学之间的协作能力,改善糖尿病足骨髓炎患者的护理。

More Specialties, Fewer Problems: Using Collaborative Competency Between Infectious Diseases, Podiatry, and Pathology to Improve the Care of Patients with Diabetic Foot Osteomyelitis.

机构信息

*Division of Infectious Diseases, Department of Medicine, Boston, MA.

¶Harvard Medical School, Boston, MA.

出版信息

J Am Podiatr Med Assoc. 2022 Nov-Dec;112(6). doi: 10.7547/20-178.

DOI:10.7547/20-178
PMID:33630067
Abstract

BACKGROUND

Diabetic foot osteomyelitis is a common infection where treatment involves multiple services, including infectious diseases, podiatry, and pathology. Despite its ubiquity in the hospital, consensus on much of its management is lacking.

METHODS

Representatives from infectious diseases, podiatry, and pathology interested in quality improvement developed multidisciplinary institutional recommendations culminating in an educational intervention describing optimal diagnostic and therapeutic approaches to diabetic foot osteomyelitis (DFO). Knowledge acquisition was assessed by preintervention and postintervention surveys. Inpatients with forefoot DFO were retrospectively reviewed before and after intervention to assess frequency of recommended diagnostic and therapeutic maneuvers, including appropriate definition of surgical bone margins, definitive histopathology reports, and unnecessary intravenous antibiotics or prolonged antibiotic courses.

RESULTS

A postintervention survey revealed significant improvements in knowledge of antibiotic treatment duration and the role of oral antibiotics in managing DFO. There were 104 consecutive patients in the preintervention cohort (April 1, 2018, to April 1, 2019) and 32 patients in the postintervention cohort (November 5, 2019, to March 1, 2020), the latter truncated by changes in hospital practice during the coronavirus disease 2019 pandemic. Noncategorizable or equivocal disease reports decreased from before intervention to after intervention (27.0% versus 3.3%, respectively; P = .006). We observed nonsignificant improvement in correct bone margin definition (74.0% versus 87.5%; P = .11), unnecessary peripherally inserted central catheter line placement (18.3% versus 9.4%; P = .23), and unnecessary prolonged antibiotics (21.9% versus 5.0%; P = .10). In addition, by working as an interdisciplinary group, many solvable misunderstandings were identified, and processes were adjusted to improve the quality of care provided to these patients.

CONCLUSIONS

This quality improvement initiative regarding management of DFO led to improved provider knowledge and collaborative competency between these three departments, improvements in definitive pathology reports, and nonsignificant improvement in several other clinical endpoints. Creating collaborative competency may be an effective local strategy to improve knowledge of diabetic foot infection and may generalize to other common multidisciplinary conditions.

摘要

背景

糖尿病足骨髓炎是一种常见的感染,其治疗需要多学科的参与,包括传染病学、足病学和病理学。尽管这种感染在医院中普遍存在,但对于其大部分治疗方法仍缺乏共识。

方法

对质量改进感兴趣的传染病学、足病学和病理学代表共同制定了多学科机构建议,最终形成了一项教育干预措施,描述了治疗糖尿病足骨髓炎(DFO)的最佳诊断和治疗方法。通过干预前后的调查评估知识获取情况。对干预前后的前足 DFO 住院患者进行回顾性分析,以评估推荐的诊断和治疗操作的频率,包括对手术骨边缘的适当定义、明确的组织病理学报告以及不必要的静脉内抗生素或延长抗生素疗程。

结果

干预后调查显示,抗生素治疗持续时间和口服抗生素在管理 DFO 中的作用的知识有显著提高。在干预前队列(2018 年 4 月 1 日至 2019 年 4 月 1 日)中有 104 例连续患者,在干预后队列(2019 年 11 月 5 日至 2020 年 3 月 1 日)中有 32 例,由于在冠状病毒病 2019 大流行期间医院实践的变化,后一队列的病例数量减少。无法分类或不确定的疾病报告从干预前到干预后减少(分别为 27.0%和 3.3%;P =.006)。我们观察到正确的骨边缘定义没有显著改善(分别为 74.0%和 87.5%;P =.11),不必要的外周插入中心导管线放置(分别为 18.3%和 9.4%;P =.23),以及不必要的延长抗生素疗程(分别为 21.9%和 5.0%;P =.10)。此外,通过作为一个跨学科小组工作,解决了许多可解决的误解,并调整了流程,以提高对这些患者的护理质量。

结论

这项针对糖尿病足骨髓炎管理的质量改进举措提高了提供者的知识,改善了这三个部门之间的协作能力,提高了明确的病理学报告,并且在其他几个临床终点方面没有显著改善。建立协作能力可能是提高糖尿病足感染知识的有效局部策略,并可能推广到其他常见的多学科疾病。

相似文献

1
More Specialties, Fewer Problems: Using Collaborative Competency Between Infectious Diseases, Podiatry, and Pathology to Improve the Care of Patients with Diabetic Foot Osteomyelitis.更多专业,更少问题:利用传染病学、足病学和病理学之间的协作能力,改善糖尿病足骨髓炎患者的护理。
J Am Podiatr Med Assoc. 2022 Nov-Dec;112(6). doi: 10.7547/20-178.
2
Residual osteomyelitis at the resection margin after conservative surgery is not associated with the recurrence of diabetic foot infection and may successfully be treated without postoperative antibiotic therapy.保守手术后切除边缘残留骨髓炎与糖尿病足感染的复发无关,且无需术后抗生素治疗即可成功治愈。
Diabet Med. 2023 Oct;40(10):e15162. doi: 10.1111/dme.15162. Epub 2023 Jun 18.
3
Controversial Issues Regarding Positive Bone Margins in Surgery for Diabetic Foot Osteomyelitis: A Pilot Study.糖尿病足骨髓炎手术中阳性骨缘的争议问题:一项初步研究。
Int J Low Extrem Wounds. 2024 Mar;23(1):109-115. doi: 10.1177/15347346211041267. Epub 2021 Sep 7.
4
Treating Diabetic Foot Osteomyelitis: A Practical State-of-the-Art Update.治疗糖尿病足骨髓炎:实用的最新技术进展
Medicina (Kaunas). 2021 Apr 1;57(4):339. doi: 10.3390/medicina57040339.
5
Difficult situations managing diabetic foot. Evidences and personal views: is to operate on patients with diabetic foot osteomyelitis old-fashioned?糖尿病足管理中的困难情况。证据与个人观点:对糖尿病足骨髓炎患者进行手术是否过时?
Int J Low Extrem Wounds. 2014 Dec;13(4):241-6. doi: 10.1177/1534734614554282.
6
Infected bone resection plus adjuvant antibiotic-impregnated calcium sulfate versus infected bone resection alone in the treatment of diabetic forefoot osteomyelitis.感染性骨切除加辅助抗生素浸渍硫酸钙与单纯感染性骨切除治疗糖尿病前足骨髓炎的比较。
BMC Musculoskelet Disord. 2019 May 24;20(1):246. doi: 10.1186/s12891-019-2635-8.
7
Investigation and management of diabetic foot osteomyelitis: An update for the foot and ankle orthopaedic surgeon.糖尿病足骨髓炎的调查与管理:给足踝骨科医生的最新资讯
J Clin Orthop Trauma. 2023 Dec 31;48:102330. doi: 10.1016/j.jcot.2023.102330. eCollection 2024 Jan.
8
The effectiveness of systemic antibiotics for osteomyelitis of the foot in adults with diabetes mellitus: a systematic review protocol.成人糖尿病足骨髓炎全身抗生素治疗效果的系统评价方案。
J Foot Ankle Res. 2022 Jun 17;15(1):48. doi: 10.1186/s13047-022-00554-3.
9
Advances in pharmacotherapy for diabetic foot osteomyelitis.糖尿病足骨髓炎的药物治疗进展。
Expert Opin Pharmacother. 2021 Nov;22(16):2281-2291. doi: 10.1080/14656566.2021.1954159. Epub 2021 Jul 29.
10
Local Antibiotic Delivery Systems in the Surgical Treatment of Diabetic Foot Osteomyelitis: Again, No Benefit?局部抗生素给药系统在糖尿病足骨髓炎外科治疗中的应用:再次证明无效?
Int J Low Extrem Wounds. 2022 Dec;21(4):555-561. doi: 10.1177/1534734620973961. Epub 2020 Dec 9.

引用本文的文献

1
Not All in Vein: Oral Antibiotics for Diabetic Foot Osteomyelitis: A Narrative Review.并非全靠静脉给药:用于糖尿病足骨髓炎的口服抗生素:一项叙述性综述
J Clin Med. 2025 Feb 20;14(5):1405. doi: 10.3390/jcm14051405.
2
Outpatient Parenteral Antibiotic Therapy for Diabetic Foot Osteomyelitis in an Uninsured and Underinsured Cohort.未参保及参保不足人群糖尿病足骨髓炎的门诊胃肠外抗生素治疗
Infect Dis Clin Pract (Baltim Md). 2023 Mar;31(2). doi: 10.1097/ipc.0000000000001219. Epub 2023 Jan 10.
3
Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk.
氟喹诺酮类药物在 FDA 发布与主动脉瘤风险相关的药物安全通信后用于治疗糖尿病足感染。
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0070821. doi: 10.1128/AAC.00708-21.